J S March

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)
    J S March
    Department of Psychiatry, DUMC, Durham, NC 27710, USA
    J Abnorm Child Psychol 28:527-41. 2000
  2. ncbi request reprint A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA
    Biol Psychiatry 62:1149-54. 2007
  3. ncbi request reprint The Child and Adolescent Psychiatry Trials Network (CAPTN)
    John S March
    Department of Psychiatry and Behavioral Sciences and the Duke Clinical Research Institute at Duke University Medical Center, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 43:515-8. 2004
  4. ncbi request reprint AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology
    John March
    Duke University Medical Center, Durham, NC 27705, USA
    J Am Acad Child Adolesc Psychiatry 43:1046-56. 2004
  5. ncbi request reprint Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial
    John March
    Duke Clinical Research Institute, Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 292:807-20. 2004
  6. ncbi request reprint Using and teaching evidence-based medicine: the Duke University child and adolescent psychiatry model
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, Duke University Medical Center, 718 Rutherford Street DUMC 3527, Durham, NC 27710, USA
    Child Adolesc Psychiatr Clin N Am 14:273-96, viii-ix. 2005
  7. ncbi request reprint Advances in paediatric neuropsychopharmacology: an overview
    J S March
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Int J Neuropsychopharmacol 4:141-7. 2001
  8. ncbi request reprint Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Child Adolesc Psychopharmacol 16:91-102. 2006
  9. ncbi request reprint Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder
    J S March
    Department of Psychiatry, Duke University Medical Center, Box 3527, Durham, NC 27710, USA
    J Clin Child Psychol 30:8-18. 2001
  10. ncbi request reprint AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry
    John S March
    Department of Psychiatry, Duke University Medical Center, Child and Family Study Center, 718 Rutherford Street, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 46:1098-110. 2007

Research Grants

Collaborators

Detail Information

Publications69

  1. ncbi request reprint Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)
    J S March
    Department of Psychiatry, DUMC, Durham, NC 27710, USA
    J Abnorm Child Psychol 28:527-41. 2000
    ..When treating ADHD, it is important to search for comorbid anxiety and negative affectivity and to adjust treatment strategies accordingly...
  2. ncbi request reprint A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA
    Biol Psychiatry 62:1149-54. 2007
    ..Social anxiety disorder, which occurs in 2% to 5% of children and adolescents, is associated with significant distress and functional impairment...
  3. ncbi request reprint The Child and Adolescent Psychiatry Trials Network (CAPTN)
    John S March
    Department of Psychiatry and Behavioral Sciences and the Duke Clinical Research Institute at Duke University Medical Center, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 43:515-8. 2004
    ..The current generation of clinical trials in pediatric psychiatry often fails to maximize clinical utility for practicing clinicians, thereby diluting its impact...
  4. ncbi request reprint AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology
    John March
    Duke University Medical Center, Durham, NC 27705, USA
    J Am Acad Child Adolesc Psychiatry 43:1046-56. 2004
    ..The purpose was to identify challenges and their solutions regarding the use of placebo in randomized controlled trials in pediatric psychopharmacology...
  5. ncbi request reprint Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial
    John March
    Duke Clinical Research Institute, Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 292:807-20. 2004
    ..Initial treatment of major depressive disorder in adolescents may include cognitive-behavioral therapy (CBT) or a selective serotonin reuptake inhibitor (SSRI). However, little is known about their relative or combined effectiveness...
  6. ncbi request reprint Using and teaching evidence-based medicine: the Duke University child and adolescent psychiatry model
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, Duke University Medical Center, 718 Rutherford Street DUMC 3527, Durham, NC 27710, USA
    Child Adolesc Psychiatr Clin N Am 14:273-96, viii-ix. 2005
    ....
  7. ncbi request reprint Advances in paediatric neuropsychopharmacology: an overview
    J S March
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Int J Neuropsychopharmacol 4:141-7. 2001
    ..In this introductory section, these articles are placed in the context of the state-of-the field and, more specifically, within the framework of recent NIMH initiatives in paediatric neuropsychopharmacology...
  8. ncbi request reprint Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Child Adolesc Psychopharmacol 16:91-102. 2006
    ..The aim of this study was to examine the balance between the benefits of treatment and the risk of suicidality in children and adolescents in multicenter, randomized, controlled trials of sertraline versus placebo...
  9. ncbi request reprint Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder
    J S March
    Department of Psychiatry, Duke University Medical Center, Box 3527, Durham, NC 27710, USA
    J Clin Child Psychol 30:8-18. 2001
    ....
  10. ncbi request reprint AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry
    John S March
    Department of Psychiatry, Duke University Medical Center, Child and Family Study Center, 718 Rutherford Street, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 46:1098-110. 2007
    ..quot;..
  11. ncbi request reprint Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial
    J S March
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 280:1752-6. 1998
    ..The serotonin reuptake inhibitors are the treatment of choice for patients with obsessive-compulsive disorder; however, empirical support for this assertion has been weaker for children and adolescents than for adults...
  12. ncbi request reprint Test-retest reliability of the Multidimensional Anxiety Scale for Children
    J S March
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27740, USA
    J Anxiety Disord 13:349-58. 1999
    ..Stability was unaffected by age or gender, but was lower for African American than Caucasian subjects. Satisfactory test-retest reliability also was demonstrated for two empirically derived subscales, the MASC-10 and Anxiety Index...
  13. ncbi request reprint The case for practical clinical trials in psychiatry
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, 718 Rutherford St, Durham, NC 27705, USA
    Am J Psychiatry 162:836-46. 2005
    ..The authors present the case for psychiatry's adoption of the practical clinical trials model, which is widely used in research in other areas of medicine...
  14. ncbi request reprint Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study
    K C Wells
    Duke University Medical Center, Durham, North Carolina, USA
    J Abnorm Child Psychol 28:543-53. 2000
    ..Results are discussed in terms of the theoretical and empirically documented importance of negative parenting in the symptoms, comorbidities and long-term outcomes of ADHD...
  15. ncbi request reprint Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial
    L L Greenhill
    Clinical Psychiatry, Department of Psychiatry, Columbia University, New York, USA
    J Am Acad Child Adolesc Psychiatry 40:180-7. 2001
    ....
  16. ncbi request reprint Multimodal treatment of ADHD in the MTA: an alternative outcome analysis
    C K Conners
    Attention Deficit Disorder Program, DUMC, 2200 West Main Street, Suite 230B, Durham, NC 27715, USA
    J Am Acad Child Adolesc Psychiatry 40:159-67. 2001
    ....
  17. ncbi request reprint Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents
    S N Compton
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 39:1040-6. 2000
    ....
  18. ncbi request reprint Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder
    J N Epstein
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA
    Neuropsychology 11:467-73. 1997
    ..This specific pattern of dysfunction was interpreted as a difficulty with maintaining attention possibly associated with anterior attention mechanisms in the right hemisphere...
  19. ncbi request reprint Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder
    Karen C Wells
    Department of Psychiatry, Duke University Medical Center, Durham, NC, USA
    J Consult Clin Psychol 74:649-57. 2006
    ..The authors discuss the importance of changes in parenting behavior for families of children with ADHD and the need for reliable and objective measures in evaluating treatment outcome...
  20. ncbi request reprint The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks
    John March
    Department of Psychiatry, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 45:1393-403. 2006
    ..Taking benefit and risk into account, we conclude that the combination of FLX and CBT appears superior to either monotherapy as a treatment for moderate to severe major depressive disorder in adolescents...
  21. ncbi request reprint Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS)
    John Curry
    Duke Child and Family Study Center, NC 27705, USA
    J Am Acad Child Adolesc Psychiatry 45:1427-39. 2006
    ....
  22. ncbi request reprint Pharmacological management of treatment-resistant pediatric depression
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68195 5581, USA
    J Am Acad Child Adolesc Psychiatry 44:198-200. 2005
  23. pmc Recovery and recurrence following treatment for adolescent major depression
    John Curry
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA
    Arch Gen Psychiatry 68:263-9. 2011
    ..Major depressive disorder in adolescents is common and impairing. Efficacious treatments have been developed, but little is known about longer-term outcomes, including recurrence...
  24. doi request reprint The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up
    John March
    Department of Psychiatry and Behavioral Sciences and the Duke Clinical Research Institute at Duke University Medical Center, Durham, NC 27705, USA
    Am J Psychiatry 166:1141-9. 2009
    ..The authors report effectiveness outcomes across a 1-year naturalistic follow-up period...
  25. ncbi request reprint Sertraline in children and adolescents with social anxiety disorder: an open trial
    S N Compton
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 40:564-71. 2001
    ..The aim of this open-label study was to assess the therapeutic benefits, response pattern, and safety of sertraline in children with social anxiety disorder...
  26. ncbi request reprint Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government
    Joseph DeVeaugh-Geiss
    Duke Clinical Research Institute, Durham, NC 27715, USA
    J Am Acad Child Adolesc Psychiatry 45:261-70. 2006
    ..To give academic researchers, government officials, and industry scientists an opportunity to assess the state of pediatric psychopharmacology and identify challenges facing professionals in the field...
  27. ncbi request reprint Psychopharmacology of pediatric posttraumatic stress disorder
    C L Donnelly
    Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
    J Child Adolesc Psychopharmacol 9:203-20. 1999
    ..To review the current knowledge of pharmacotherapy in the treatment of Post-traumatic Stress Disorder (PTSD) as it applies to children and adolescents and to provide a rational approach to medication use in Pediatric PTSD...
  28. ncbi request reprint Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS)
    Diane E May
    University of Nebraska Medical Center, Omaha, NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 46:801-10. 2007
    ..To examine factors associated with eligibility and randomization and consider the efficiency of recruitment methods...
  29. ncbi request reprint Assessing medication effects in the MTA study using neuropsychological outcomes
    Jeffery N Epstein
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Child Psychol Psychiatry 47:446-56. 2006
    ....
  30. ncbi request reprint Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198, USA
    J Child Adolesc Psychopharmacol 16:11-24. 2006
    ..The authors have concluded that SSRIs -- in particular, fluoxetine -- do have a role in the treatment of pediatric depression...
  31. doi request reprint Cost-effectiveness of treatments for adolescent depression: results from TADS
    Marisa Elena Domino
    Department of Health Policy and Administration, School of Public Health, University of North Carolina at Chapel Hill, 1104G McGavran Greenberg Hall, CB 7411, Chapel Hill, NC 27599, USA
    Am J Psychiatry 165:588-96. 2008
    ..Treatment costs are a relevant concern given the competing demands on family and health care budgets. The authors evaluated the cost-effectiveness of three active treatments among adolescents with major depressive disorder...
  32. ncbi request reprint Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial
    Jeffery N Epstein
    Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45206, USA
    Arch Pediatr Adolesc Med 161:835-40. 2007
    ..To test whether adoption of a collaborative consultative service model results in improved patient outcomes...
  33. pmc Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy
    Paul Rohde
    Oregon Research Institute, 1715 Franklin Blvd, Eugene, OR 97403 1983, USA
    Arch Gen Psychiatry 65:447-55. 2008
    ..Treatment consisted of 3 stages: (1) acute (12 weeks), (2) continuation (6 weeks), and (3) maintenance (18 weeks)...
  34. ncbi request reprint Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder
    Scott H Kollins
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    Biol Psychiatry 62:951-3. 2007
  35. ncbi request reprint Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review
    Scott N Compton
    Pediatric Psychiatry, Duke University Medical Center, DUMC Box 3527, Durham, NC 27710, USA
    Pediatr Ann 36:586-90, 592, 594-8. 2007
  36. ncbi request reprint Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA
    Biol Psychiatry 61:344-7. 2007
    ..The presence of a comorbid tic disorder may predict a poorer outcome in the acute treatment of pediatric obsessive-compulsive disorder (OCD)...
  37. ncbi request reprint The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Arch Gen Psychiatry 64:1132-43. 2007
    ..The Treatment for Adolescents With Depression Study evaluates the effectiveness of fluoxetine hydrochloride therapy, cognitive behavior therapy (CBT), and their combination in adolescents with major depressive disorder...
  38. ncbi request reprint Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS)
    Benedetto Vitiello
    Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, MD 20892 9633, USA
    J Am Acad Child Adolesc Psychiatry 46:1642-50. 2007
    ..We examined the extent to which parents and adolescents participating in the Treatment for Adolescents With Depression Study (TADS) understood key aspects of the study...
  39. ncbi request reprint 3-year follow-up of the NIMH MTA study
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Unit 78, Columbia University NYSPI, 1051 Riverside Drive, New York, NY 10027, USA
    J Am Acad Child Adolesc Psychiatry 46:989-1002. 2007
    ..This report examines 36-month outcomes, 2 years after treatment by the study ended...
  40. ncbi request reprint Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1003-14. 2007
    ....
  41. ncbi request reprint Effects of stimulant medication on growth rates across 3 years in the MTA follow-up
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1015-27. 2007
    ..To evaluate the hypothesis of stimulant medication effect on physical growth in the follow-up phase of the Multimodal Treatment Study of Children With ADHD...
  42. ncbi request reprint Empirically derived subtypes of adolescent depression: latent profile analysis of co-occurring symptoms in the Treatment for Adolescents with Depression Study (TADS)
    Keith C Herman
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287 3325, USA
    J Consult Clin Psychol 75:716-28. 2007
    ..The discussion focuses on understanding subtypes and comorbidity in adolescent depression as well as the implications for treatment and for prevention...
  43. ncbi request reprint Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study
    Sanjeev Pathak
    University of Cincinnati College of Medicine, Children s Hospital Medical Center, MLC D 3014, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Curr Psychiatry Rep 7:429-34. 2005
    ..Moreover, the study results confirm that fluoxetine alone is effective in the treatment of depressed adolescents...
  44. ncbi request reprint Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution
    Howard Abikoff
    Child and Adolescent Psychiatry, NYU Child Study Center, NYU School of Medicine, NY 10016, USA
    J Am Acad Child Adolesc Psychiatry 41:498-504. 2002
    ..Although the manual-based guidelines are especially applicable to multisite RCTs, many of the procedures in the ASAP Manual can apply to any treatment study in children...
  45. ncbi request reprint Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA
    James M Swanson
    Department of Pediatrics, University of California, Irvine 92612, USA
    J Abnorm Child Psychol 30:327-32. 2002
    ..Finally, we invite others to use the large and rich data set that will soon be available in the public domain, to perform secondary analyses to mine the meaning of the MTA and to evaluate theories of ADHD and response to treatments...
  46. ncbi request reprint The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods
    Martin Franklin
    Center for the Treatment and Study of Anxiety, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    J Child Adolesc Psychopharmacol 13:S39-51. 2003
    ..All patients, regardless of responder status, return for all scheduled assessments. This report describes the design of the trial, the rationale for the design choices made, and the methods used to carry out the trial...
  47. ncbi request reprint Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial
    Cathryn A Galanter
    Columbia University New York State Psychiatric Institute, New York, New York 10032, USA
    J Child Adolesc Psychopharmacol 13:123-36. 2003
    ..Recent reports raise concern that children with attention deficit hyperactivity disorder (ADHD) and some manic symptoms may worsen with stimulant treatment. This study examines the response to methylphenidate in such children...
  48. ncbi request reprint Review of safety assessment methods used in pediatric psychopharmacology
    Laurence L Greenhill
    New York State Psychiatric Institute Columbia University, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:627-33. 2003
    ..Elicitation is an essential and critical step in ascertaining adverse events (AEs). This report reviews elicitation methods used in published clinical trials of psychopharmacological agents in children...
  49. ncbi request reprint Socioeconomic status as a moderator of ADHD treatment outcomes
    Ricardo Rieppi
    Department of Psychology, St Johns University, Jamaica, NY 11439, USA
    J Am Acad Child Adolesc Psychiatry 41:269-77. 2002
    ....
  50. ncbi request reprint Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000
    Laurence L Greenhill
    New York State Psychiatric Institute, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:651-5. 2003
    ..To improve the methods for long-term assessment of drug-associated side effects and advance knowledge of the safety profile of psychotropic medications in children and adolescents...
  51. ncbi request reprint Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD
    L Eugene Arnold
    Department of Psychiatry, Ohio State University, USA
    J Consult Clin Psychol 71:713-27. 2003
    ..Treatment for lower socioeconomic status minority children, especially if comorbid, should combine medication and behavioral treatment...
  52. ncbi request reprint An evidence-based medicine approach to combined treatment for ADHD in children and adolescents
    Douglas G Kondo
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27705, USA
    Psychopharmacol Bull 37:7-23. 2003
    ....
  53. pmc Authors of TADS study reply to letter raising concerns
    John S March
    BMJ 330:730-1. 2005
  54. ncbi request reprint Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder
    Betsy Hoza
    Department of Psychological Sciences, Purdue University, West Lafayette, IN 47907 2081, USA
    J Clin Child Adolesc Psychol 34:74-86. 2005
    ..Results indicated that children from all groups remained significantly impaired in their peer relationships...
  55. ncbi request reprint Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial
    Paula Barrett
    School of Applied Psychology, Griffith University, Australia
    J Am Acad Child Adolesc Psychiatry 43:46-62. 2004
    ..To evaluate the relative efficacy of (1) individual cognitive-behavioral family-based therapy (CBFT); (2) group CBFT; and (3) a waitlist control group in the treatment of childhood obsessive-compulsive disorder (OCD)...
  56. ncbi request reprint Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures
    L Eugene Arnold
    The Ohio State University, Columbus, Ohio, USA
    J Abnorm Child Psychol 32:39-51. 2004
    ....
  57. ncbi request reprint Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review
    Scott N Compton
    Department of Psychiatry and Behavioral Psychology, Duke University Medical Center, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 43:930-59. 2004
    ..To review the literature on the cognitive-behavioral treatment of children and adolescents with anxiety and depressive disorders within the conceptual framework of evidence-based medicine...
  58. ncbi request reprint The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198 5581, USA
    CNS Drugs 18:957-66. 2004
    ....
  59. ncbi request reprint A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Child Adolesc Psychopharmacol 17:175-85. 2007
    ..The purpose of this study was to assess the effectiveness and tolerability of atomoxetine during acute treatment of attention-deficit/hyperactivity disorder (ADHD) in 5 and 6 year olds...
  60. ncbi request reprint Pharmacotherapy of childhood anxiety disorders
    Christopher J Kratochvil
    Department of Child and Adolescent Psychiatry, University of Nebraska Medical Center, 44th and Emile, Omaha, NE 68198, USA
    Curr Psychiatry Rep 4:264-9. 2002
    ..This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders...
  61. ncbi request reprint Observed classroom behavior of children with ADHD: relationship to gender and comorbidity
    Howard B Abikoff
    New York University School of Medicine, New York, USA
    J Abnorm Child Psychol 30:349-59. 2002
    ....
  62. ncbi request reprint Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?
    Lisa Giulino
    Child and Family Study Center, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Child Adolesc Psychopharmacol 12:157-64. 2002
    ..Additional research is required to define the boundaries of PANDAS and to develop psychometrically reliable and valid diagnostic strategies...
  63. ncbi request reprint Development and natural history of mood disorders
    E Jane Costello
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    Biol Psychiatry 52:529-42. 2002
    ..A diverse program of multidisciplinary research is recommended to reduce the burden on children and families affected with these conditions...
  64. ncbi request reprint Behavioral avoidance test for childhood obsessive-compulsive disorder: a home-based observation
    Paula Barrett
    School of Applied Psychology, Griffith University, Mount Gravatt, Queensland, 4122, Australia
    Am J Psychother 57:80-100. 2003
    ..The results of the current study strongly support the sensitivity of a standardized BAT in assessing treatment-related changes in children and adolescents with OCD. Implications and future directions for research are discussed...
  65. ncbi request reprint Which treatment for whom for ADHD? Moderators of treatment response in the MTA
    Elizabeth B Owens
    Institute of Human Development, University of California, Berkeley 94720 1690, USA
    J Consult Clin Psychol 71:540-52. 2003
    ..No predictors or moderators emerged for behavioral and community comparison treatments. The authors discuss conceptual and clinical implications of research on treatment moderators...
  66. ncbi request reprint Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects
    Brooke S G Molina
    Department of Psychiatry, University of Pittsburgh School of Medicine, 3811 O Hara Street, Pittsburgh, PA 15213, USA
    J Am Acad Child Adolesc Psychiatry 46:1028-40. 2007
    ....
  67. ncbi request reprint A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS)
    Diane E May
    University of Nebraska Medical Center, Omaha, NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 46:573-81. 2007
    ..To describe a manual-based intervention to address clinical crises and retain participants in the Treatment for Adolescents With Depression Study (TADS)...
  68. ncbi request reprint Clinical practice guidelines
    Peter Szatmari
    J Am Acad Child Adolesc Psychiatry 46:939-40; discussion 940-2. 2007
  69. ncbi request reprint How can we improve the assessment of safety in child and adolescent psychopharmacology?
    Benedetto Vitiello
    Division of Services and Intervention Research, NIMH, Bethesda, MD 20982 9633, USA
    J Am Acad Child Adolesc Psychiatry 42:634-41. 2003
    ..To identify approaches to improving methods for assessing tolerability and safety of psychotropic medications in children and adolescents...

Research Grants5

  1. RESEARCH IN PEDIATRIC ANXIETY DISORDERS
    John March; Fiscal Year: 2007
    ..abstract_text> ..
  2. Child and Adolescent Anxiety Multisite Study (CAMS)
    John March; Fiscal Year: 2007
    ....
  3. Child and Adolescent Psychiatry Trials Network (CAPTN)
    John March; Fiscal Year: 2007
    ..abstract_text> ..
  4. Family Based Treatment of Early Childhood OCD
    John March; Fiscal Year: 2007
    ....